IRIS
CIMADAMORE, Alessia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.260
EU - Europa 541
NA - Nord America 541
SA - Sud America 291
AF - Africa 88
OC - Oceania 2
Totale 2.723
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 790
US - Stati Uniti d'America 528
BR - Brasile 261
RU - Federazione Russa 201
IT - Italia 181
KR - Corea 177
CN - Cina 124
TG - Togo 67
HK - Hong Kong 55
DE - Germania 46
IN - India 35
AT - Austria 24
GB - Regno Unito 17
TR - Turchia 17
NL - Olanda 13
IQ - Iraq 11
AR - Argentina 10
FR - Francia 10
IE - Irlanda 10
FI - Finlandia 9
EC - Ecuador 8
CA - Canada 7
BD - Bangladesh 6
ES - Italia 6
JP - Giappone 5
LT - Lituania 5
TN - Tunisia 5
VN - Vietnam 5
AE - Emirati Arabi Uniti 4
ZA - Sudafrica 4
CO - Colombia 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GR - Grecia 3
ID - Indonesia 3
IR - Iran 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
MX - Messico 3
PE - Perù 3
PK - Pakistan 3
PL - Polonia 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
DZ - Algeria 2
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
Totale 2.723
Salva come PNG Salva come JPEG
Città #
Singapore 306
Boardman 198
Seoul 177
Beijing 95
Lomé 67
Ogden 59
Hong Kong 50
Milan 29
Rome 21
Ashburn 18
Frankfurt am Main 18
Nuremberg 18
São Paulo 18
Hyderabad 17
The Dalles 14
Codroipo 13
Vienna 11
Dublin 10
Naples 9
New York 8
Amsterdam 7
Rio de Janeiro 7
Shanghai 7
Belo Horizonte 6
Orta Nova 6
Porto Alegre 6
Balıkesir 5
Düsseldorf 5
Lappeenranta 5
Los Angeles 5
Tunis 5
Bengaluru 4
Campinas 4
Columbus 4
Curitiba 4
Helsinki 4
Istanbul 4
Karbala 4
Madrid 4
Porcia 4
Seattle 4
Xi'an 4
Al Hillah 3
Araçatuba 3
Atlanta 3
Brasília 3
Guayaquil 3
Hanoi 3
Jaboatão dos Guararapes 3
London 3
Nairobi 3
Passo Fundo 3
Portsmouth 3
Ribeirão Preto 3
Santa Clara 3
Secaucus 3
Sumaré 3
Tokyo 3
Trabzon 3
Warsaw 3
Aligarh 2
Ancona 2
Angra dos Reis 2
Aracaju 2
Araraquara 2
Athens 2
Bari 2
Belford Roxo 2
Bhubaneswar 2
Cabo Frio 2
Cagliari 2
Caraguatatuba 2
Castiglione delle Stiviere 2
Catanduva 2
Cavaso del Tomba 2
Cerquilho 2
Chicago 2
Criciúma 2
Dallas 2
Diamantina 2
Dongguan 2
Duque de Caxias 2
Erbil 2
Foggia 2
Frosinone 2
Giza 2
Goiânia 2
Gramado 2
Greenwood 2
Groningen 2
Guarulhos 2
Isfahan 2
Islamabad 2
Jeddah 2
Jequié 2
Kolkata 2
Kuwait City 2
La Plata 2
Lagoa da Prata 2
Limeira 2
Totale 1.398
Salva come PNG Salva come JPEG
Nome #
News in the classification of WHO 2022 bladder tumors 101
SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP) 53
Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis 46
How To Report the Minor Component of a High-grade Pattern in Radical Prostatectomy Specimens: Time To Abandon the “Tertiary” Terminology? 35
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 32
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group 31
Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments 29
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors 29
Histopathology of Prostate Cancer and its Precursors 29
Epigenetic modulations and lineage plasticity in advanced prostate cancer 29
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer 29
Digital real-time microscopy of ex-vivo tissues: A novel strategy to control surgical accuracy 27
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature 27
Re: Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population 27
Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis 25
A gender-related dichotomy in bladder cancer 25
Epigenetic modifications and modulators in prostate cancer 25
Patients ask and pathologists answer: ten questions around prostate cancer grading 24
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 24
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 24
Targeted treatment of renal cell carcinoma 24
Re: Friederike Haidl, David Pfister, Axel Heidenreich. Re: Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. Mordasini L, Hechelhammer L, Diener PA, et al. J Vasc Interv Radiol 2018;29:589–97. Eur Urol 2018;74:525–6: Could Morphologic Changes in Periprostatic Arteries Have an Influence on Prostatic Artery Embolization? 24
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial 23
The most effective but largely ignored target for prostate cancer early detection and intervention 23
Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer 23
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming? 23
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis 22
An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt 22
Digital Frozen Sections with Fluorescence Confocal Microscopy During Robot-assisted Radical Prostatectomy: Surgical Technique 22
The uropathologist of the future: getting ready with intelligence for the prostate cancer tsunami 21
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 21
An update on investigational therapies that target STAT3 for the treatment of cancer 21
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 21
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 20
Morphologic spectrum of the epithelial tumors of the male and female urethra 20
Tumors of the Urinary System and Male Genital Organs: 2022 World Health Organization Classification and Multidisciplinarity 20
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 20
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series 20
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward 20
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis 20
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 20
OUTCOMES OF DIFFERENT PATTERN OF SEMINAL VESICLE INVASION IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY 19
Designing novel immunocombinations in metastatic renal cell carcinoma 19
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 19
Frequent Telomerase Reverse Transcriptase Promoter and Fibroblast Growth Factor Receptor 3 Mutations Support the Precursor Nature of Papillary Urothelial Hyperplasia of the Urinary Bladder 19
Re: Martha Boone. The Unfettered Urologist. What I Never Had Time to Tell You in a Fifteen Minute Office Visit. New York, NY: Morgan James Publishing; 2023 19
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 19
Surgical checklist adherence across urology expertise levels impacts transurethral resection of bladder tumour quality indicators 19
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis 19
Staging and reporting of renal cell carcinomas 19
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives 18
The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy 18
Variants and new entities of bladder cancer 18
Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667–75: How Does Circulating DNA Reach the Blood Stream? 18
Towards a new WHO classification of renal cell tumor: What the clinician needs to know-a narrative review 18
Variants of Bladder Cancer: The Pathologist's Point of View 18
Biphasic Tumors of the Urogenital Tract: Selected Topics 18
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A) 18
Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype 18
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B) 18
Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489–91 17
Are liver nested stromal epithelial tumors always low aggressive? 17
Re: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy 17
Giant cell carcinoma of the urinary bladder: Clinicopathologic analysis and oncological outcomes 17
Grading of Chromophobe Renal Cell Carcinoma: Do We Need It? 17
Re: George J. Netto, Mahul B. Amin, Eva M. Compérat, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.015 17
Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer 17
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion 17
Predictive and prognostic biomarkers in urological tumours 17
An update on immunotherapy in uro-oncology 17
Bone targeting agents in patients with metastatic prostate cancer: State of the art 17
Agent-Based Learning Model for the Obesity Paradox in RCC 17
Spectrum of incipient (or precursor) lesions in the mucosa of the seminal vesicles 17
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 17
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 17
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 16
Hot topics in renal cancer pathology: implications for clinical management 16
TNM staging towards a personalized approach in metastatic urothelial carcinoma: What will the future be like?-a narrative review 16
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen 16
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? 16
Syndrome of inappropriate antidiuresis in prostate adenocarcinoma with neuroendocrine differentiation: a case report and literature review 16
Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation 16
RE: Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer, by Jones TD and Cheng L, https://doi.org/10.1016/j.urolonc.2020.12.007 (Low grade papillary intra-urothelial neoplasia) 16
Predicting future cancer burden in the United States by artificial neural networks 16
Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017: Focus on Our Personal Recollections and Observations 16
T1 bladder carcinoma with variant histology: pathological features and clinical significance 16
Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers 15
Clinicopathologic analysis of upper urinary tract carcinoma with variant histology 15
Immunotherapy in genitourinary cancers: Where are we going? 15
Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer 15
Digital pathology and COVID-19 and future crises: pathologists can safely diagnose cases from home using a consumer monitor and a mini PC 15
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution 15
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 15
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 15
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors 15
Renal Cell Carcinoma: genomic landscape and clinical implications 15
Pd-l1 inhibitors for the treatment of prostate cancer 15
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 15
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity 15
Pathology of the benign and malignant diseases of the prostate 15
Totale 2.113
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023628 0 0 0 0 0 0 1 2 512 9 60 44
2023/2024411 25 9 17 10 36 24 10 22 88 112 29 29
2024/20252.305 74 226 38 51 63 162 97 106 341 449 584 114
Totale 3.344